Lormalzi in India: A New Era in Alzheimer’s Care The launch…

Lormalzi in India: A New Era in Alzheimer’s Care

The launch of Lormalzi (donanemab) in India by Eli Lilly marks an important milestone in the evolving landscape of Alzheimer’s treatment.

This is a significant shift in the treatment of the neurodegenerative disorder, with experts describing it as one of the first therapies aimed at slowing progression of the disease in its early stages rather than merely managing symptoms.

This brings hope for patients and families and signals a broader shift towards earlier diagnosis, disease-modifying treatment, and more proactive approaches to Alzheimer’s care.

Read more at:
https://health.economictimes.indiatimes.com/news/industry/alzheimers-lormalzi-therapy-offers-hope-doctors-for-early-diagnosis-close-monitoring/131130149